Navid Goodarzi

559 total citations
25 papers, 456 citations indexed

About

Navid Goodarzi is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Navid Goodarzi has authored 25 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Biomaterials and 7 papers in Oncology. Recurrent topics in Navid Goodarzi's work include Nanoparticle-Based Drug Delivery (10 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Navid Goodarzi is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Navid Goodarzi collaborates with scholars based in Iran, Sweden and Netherlands. Navid Goodarzi's co-authors include Rassoul Dinarvand, Fatemeh Atyabi, Mohsen Amini, Reyhaneh Varshochian, Golnaz Kamalinia, Mohammad Hossein Ghahremani, Mohammad Reza Khorramizadeh, Mohammad H. Ghahremani, Seyed Nasser Ostad and Reza Mahjub and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Carbohydrate Polymers.

In The Last Decade

Navid Goodarzi

24 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Navid Goodarzi Iran 12 222 171 133 65 62 25 456
Golnaz Kamalinia Iran 11 232 1.0× 213 1.2× 122 0.9× 88 1.4× 49 0.8× 17 573
Haijun Zhong China 6 213 1.0× 189 1.1× 141 1.1× 76 1.2× 33 0.5× 7 476
Hussaini Syed Sha Qhattal United States 5 259 1.2× 260 1.5× 183 1.4× 68 1.0× 50 0.8× 5 558
Guichen Zhou China 8 259 1.2× 214 1.3× 174 1.3× 109 1.7× 65 1.0× 9 505
Elham Hatami United States 13 155 0.7× 256 1.5× 152 1.1× 46 0.7× 73 1.2× 20 637
Amit Singh United States 7 216 1.0× 308 1.8× 150 1.1× 71 1.1× 80 1.3× 7 595
Noor Alam India 13 298 1.3× 225 1.3× 153 1.2× 79 1.2× 140 2.3× 14 574
Zhen-Hai Zhang China 10 200 0.9× 351 2.1× 130 1.0× 93 1.4× 39 0.6× 12 585
Sandeep Urandur India 13 156 0.7× 197 1.2× 151 1.1× 50 0.8× 71 1.1× 16 438
Seung-Hak Ko South Korea 11 257 1.2× 193 1.1× 190 1.4× 71 1.1× 24 0.4× 11 498

Countries citing papers authored by Navid Goodarzi

Since Specialization
Citations

This map shows the geographic impact of Navid Goodarzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Goodarzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Goodarzi more than expected).

Fields of papers citing papers by Navid Goodarzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Goodarzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Goodarzi. The network helps show where Navid Goodarzi may publish in the future.

Co-authorship network of co-authors of Navid Goodarzi

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Goodarzi. A scholar is included among the top collaborators of Navid Goodarzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Goodarzi. Navid Goodarzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goodarzi, Navid & M. Rahimi-Esbo. (2023). Optimizing Hydrogen Production from Methanol Reformers by Temperature Variation and Feed Ratio Using CFD. SHILAP Revista de lepidopterología. 15(2). 194–200. 2 indexed citations
3.
Goodarzi, Navid, et al.. (2023). Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex. DARU Journal of Pharmaceutical Sciences. 31(1). 1–12. 1 indexed citations
4.
Goodarzi, Navid, et al.. (2023). Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR. Pharmaceutical Development and Technology. 28(2). 190–199. 2 indexed citations
5.
6.
Goodarzi, Navid, et al.. (2022). Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment. Journal of Drug Delivery Science and Technology. 77. 103905–103905. 11 indexed citations
7.
Goodarzi, Navid, et al.. (2021). Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel. Pharmaceutical Development and Technology. 26(4). 381–389. 12 indexed citations
8.
Irani, Shiva, et al.. (2020). Synergistic effect of microRNA and albumin-bound nanoparticles for inhibition of glioblastoma cancer cell proliferation. Brazilian Journal of Pharmaceutical Sciences. 56. 4 indexed citations
9.
Jafari, Razieh Mohammad, Moein Ala, Navid Goodarzi, & Ahmad Reza Dehpour. (2020). Does Pharmacodynamics of Drugs Change After Presenting them as Nanoparticles Like their Pharmacokinetics?. Current Drug Targets. 21(8). 807–818. 8 indexed citations
10.
Goodarzi, Navid, Mohsen Amini, Effat Souri, et al.. (2018). Dual drug delivery system of PLGA nanoparticles to reverse drug resistance by altering BAX/Bcl-2. Journal of Drug Delivery Science and Technology. 47. 291–298. 10 indexed citations
11.
Goodarzi, Navid, et al.. (2017). Preparation of human serum albumin nanoparticles using a chemometric technique. Journal of nanostructure in chemistry. 7(4). 327–335. 17 indexed citations
12.
Goodarzi, Navid, Bertil Abrahamsson, Rodrigo Cristofoletti, et al.. (2016). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin. Journal of Pharmaceutical Sciences. 105(4). 1362–1369. 18 indexed citations
13.
Goodarzi, Navid, Mohsen Amini, Effat Souri, et al.. (2016). Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells. DARU Journal of Pharmaceutical Sciences. 24(1). 21–21. 37 indexed citations
14.
15.
Goodarzi, Navid, Mohammad Reza Khoshayand, Mohsen Amini, et al.. (2014). cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: Preparation, optimization and in vitro characterization. Colloids and Surfaces B Biointerfaces. 122. 350–358. 18 indexed citations
16.
Goodarzi, Navid, Mohammad H. Ghahremani, Mohsen Amini, et al.. (2014). CD44‐Targeted Docetaxel Conjugate for Cancer Cells and Cancer Stem‐Like Cells: A Novel Hyaluronic Acid‐Based Drug Delivery System. Chemical Biology & Drug Design. 83(6). 741–752. 63 indexed citations
17.
Goodarzi, Navid, Mohsen Amini, Mohammad Hossein Ghahremani, et al.. (2013). Hyaluronic acid-drug conjugate of docetaxel and metformin to target cancer cells and cancer stem cells: Synthesis and characterization. Journal of Controlled Release. 172(1). e59–e59. 3 indexed citations
18.
Goodarzi, Navid, Reyhaneh Varshochian, Golnaz Kamalinia, Fatemeh Atyabi, & Rassoul Dinarvand. (2012). A review of polysaccharide cytotoxic drug conjugates for cancer therapy. Carbohydrate Polymers. 92(2). 1280–1293. 115 indexed citations
19.
Goodarzi, Navid, Mohammad Hossein Ghahremani, & Rassoul Dinarvand. (2011). Targeting CD44 by hyaluronic acid-based nano drug delivery systems may eradicate cancer stem cells in human breast cancer. 3. 26. 12 indexed citations
20.
Ghasem, Azizi, et al.. (2007). An estimation of the temperature of Lut desert using MODIS sensor data. SHILAP Revista de lepidopterología. 12(1). 7–15. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Golnaz Kamalinia Breakdown of academic impact, for papers by Haijun Zhong Breakdown of academic impact, for papers by Hussaini Syed Sha Qhattal Breakdown of academic impact, for papers by Guichen Zhou Breakdown of academic impact, for papers by Elham Hatami Breakdown of academic impact, for papers by Amit Singh Breakdown of academic impact, for papers by Noor Alam Breakdown of academic impact, for papers by Zhen-Hai Zhang Breakdown of academic impact, for papers by Sandeep Urandur Breakdown of academic impact, for papers by Seung-Hak Ko
Rankless by CCL
2026